.png){kind=icon}
ADA positive control testing services
Monoclonal, Polyclonal
PandA (PEG and acid) assay
Record Type:Technique
The administration of biological therapeutics has the potential to induce undesirable immunogenicity, resulting in anti-drug antibodies (ADA) which may lead to allergic reactions, altered pharmacokinetics (PK) and reduced efficacy. The biotherapeutics with long half-life or high dosing or the targets may interfere with the detection of ADAs causing false negative (from drug) or false positive results (from target). To overcome these limitations, a precipitation and acid dissociation assay, also called PEG and acid (PandA) assay has been developed. The method aims to detect total ADA (free ADA and drug bound ADA) in the presence of drug in samples.
First, the samples are incubated with excess drug to saturate ADA to form drug-ADA complexes. The complexes are then precipitated using polyethylene glycol (PEG) and then subjected to an acid solution for dissociation. Free ADA (and free drug) are captured on plates and incubated with the sulfo-tagged drug for the specific detection of the ADA.
About our nonclinical animal research models: We provide the utmost care for our research animals and actively pursue advances in animal welfare. As well as ensuring the highest scientific, ethical and regulatory standards, selection of appropriate animal research models for development research is critical to developing safe and effective treatments, devices and products that protect and save lives. Just as we have ethical committee oversight for human trials, we have ethical committees overseeing all aspects of our global animal care and use programs. All of our core, nonclinical facilities are accredited by AAALAC.Learn more about our commitment to replacing, reusing and refining nonclinical research models.